Nov. 8, 2022
The medical imaging field has hit a major milestone with more than 200 FDA cleared Artificial Intelligence (AI) products now available on the market. This is a significant increase from just 50 cleared AI medical imaging products just at the end of November 2019. This growth in the AI medical imaging space is a clear indication of the increase in investment and efforts being put into bringing AI technology to the healthcare industry.

The availability of more than 200 FDA cleared AI medical imaging products presents numerous opportunities for healthcare providers to leverage AI technology to improve patient care and outcomes.

If you're interested in learning more about the current state of AI medical imaging, be sure to check out the DSI's AI-Central resource at https://aicentral.acrdsi.org/.

Related ACR News

  • ACR Strategizes for 2026 State Legislative Sessions

    ACR joined other medical societies at the AMA State Legislative Roundtable to discuss policies that impact practices and patient care.

    Read more
  • Mobile Cancer Screening Act

    ACR emphasized the importance of bringing cancer screening directly to the communities that need it most to ensure early detection and intervention.

    Read more
  • ACR Challenges BCBS Policy

    3D imaging is not routinely performed and requires added resources, including specialized software, trained personnel and physician input.

    Read more